CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
Form 483 Library → ZIIP INC → 483-3029740697-20260112
Form FDA 483 · Issued 2026-01-12

ZIIP INC — FDA Form 483 Analysis

FEI: 3029740697 · Sector: Pharmaceuticals & Sterile/OTC Drugs (Manufacturer) · Lead Investigator: David K. Chen

FDA Form 483 issued to ZIIP INC (FEI 3029740697) on 2026-01-12 following an inspection of its manufacturer operations in California. The report documents 4 inspection observations centered on Finished Product Testing, Stability & Expiration Dating, Incoming Ingredient Identity Testing & COA Qualification.

Get Full Annotated 483 Dossier + CAPA Checklist
Instant PDF + CFR Matrix ($79 vs. Redica's $289)
Buy Dossier ($79)
Need Help Fixing These 4 Citations?
Get matched with a vetted 21 CFR remediation consultant
Request Consultant

Observation-by-Observation 21 CFR Breakdown (4)

Observation #1 · 21 CFR 211.160(b)(2) Finished Product Testing, Stability & Expiration Dating
FIRST-TIME OBSERVATION
Acceptance of in-process materials
Inspector Observation Language: "Determinations of conformance to appropriate written specifications for acceptance are [not made] [deficient] for in-process materials. Specifically, observed during inspection of ZIIP INC on 2026-01-12."
Plain-English Meaning: Releasing finished batches without verifying strength/potency/microbiological specs, or placing an expiration/best-by date on labels without supporting real-time or accelerated stability data.
Standard CAPA Remediation Path: Require finished-batch microbiological (USP <2021>/<2022>), heavy metal, and active-assay release testing plus ICH stability chamber protocols supporting every label shelf-life claim.
Observation #2 · 21 CFR 211.80(d) Incoming Ingredient Identity Testing & COA Qualification
FIRST-TIME OBSERVATION
Status of Each Lot Identified
Inspector Observation Language: "Each lot of [components] [drug product containers] [closures] was not appropriately identified as to its status in terms of being quarantined, approved or rejected. Specifically, observed during inspection of ZIIP INC on 2026-01-12."
Plain-English Meaning: Failure to perform at least one test to verify the identity of every incoming dietary ingredient or raw component before use, or relying on a supplier's Certificate of Analysis (COA) without first qualifying the supplier.
Standard CAPA Remediation Path: Establish SOP-QA-004 requiring FTIR/HPLC/organoleptic identity testing on 100% of incoming dietary ingredient lots and annual audit + 3-lot confirmatory testing before relying on any vendor COA.
Observation #3 · 21 CFR 211.165(d) Finished Product Testing, Stability & Expiration Dating
FIRST-TIME OBSERVATION
Acceptance/Rejection Levels
Inspector Observation Language: "The statistical quality control criteria fail to include appropriate [acceptance levels] [rejection levels]. Specifically, observed during inspection of ZIIP INC on 2026-01-12."
Plain-English Meaning: Releasing finished batches without verifying strength/potency/microbiological specs, or placing an expiration/best-by date on labels without supporting real-time or accelerated stability data.
Standard CAPA Remediation Path: Require finished-batch microbiological (USP <2021>/<2022>), heavy metal, and active-assay release testing plus ICH stability chamber protocols supporting every label shelf-life claim.
Observation #4 · 21 CFR 314.81(b)(1)(ii) Electronic Record Data Integrity (21 CFR Part 11) & Retention
FIRST-TIME OBSERVATION
Contamination, chemical or physical change, deterioration
Inspector Observation Language: "An NDA-Field Alert Report was not submitted within three working days of receipt of information concerning [bacteriological contamination] [significant chemical, physical, or other change or deterioration] in a distributed drug product. Specifically, observed during inspection of ZIIP INC on 2026-01-12."
Plain-English Meaning: Uncontrolled spreadsheets, shared laboratory logins, missing audit trails, backdated entries, or failure to retain batch and distribution records for the statutory window.
Standard CAPA Remediation Path: Enforce unique user credentials, immutable audit trails on analytical instruments, controlled form issuance numbers, and 2-year post-expiration record retention.